A darker, grittier take on the Green Lantern lore could be coming to the DCU in the upcoming Lanterns TV series.
Lung Cancer Patient in Lantern Pharma’s Harmonic Trial Shows Durable Complete Response in Target Cancer Lesions with Survival Continuing for Nearly Two Years Lantern Pharma Inc. (NASDAQ: LTRN), an ...
Lantern Pharma Inc. (NASDAQ:LTRN)’s investigational drug LP-184 has achieved a major milestone in the fight against pediatric brain cancer, following independent validation by Johns Hopkins University ...